Emerging strains can potentially reduce the efficacy of existing vaccines and treatments. For example, if a new strain has mutations in regions targeted by vaccines, the immune system might not recognize and effectively combat the pathogen. This necessitates ongoing research and potentially the reformulation of vaccines and therapies.
